Neurogene Inc.
NGNE
$29.82
-$1.45-4.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | 0.00 | 925.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | 0.00 | 925.00K |
| Cost of Revenue | 82.28M | 74.89M | 69.72M | 68.77M | 65.15M |
| Gross Profit | -82.28M | -74.89M | -69.72M | -68.77M | -64.22M |
| SG&A Expenses | 28.36M | 28.32M | 27.60M | 26.93M | 25.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 110.64M | 103.21M | 97.32M | 95.70M | 90.68M |
| Operating Income | -110.64M | -103.21M | -97.32M | -95.70M | -89.75M |
| Income Before Tax | -98.64M | -90.35M | -85.13M | -84.39M | -80.87M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -98.64 | -90.35 | -85.13 | -84.39 | -80.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -98.64M | -90.35M | -85.13M | -84.39M | -80.87M |
| EBIT | -110.64M | -103.21M | -97.32M | -95.70M | -89.75M |
| EBITDA | -107.45M | -100.12M | -94.22M | -92.57M | -86.57M |
| EPS Basic | -4.54 | -4.23 | -4.12 | -4.32 | -4.36 |
| Normalized Basic EPS | -2.84 | -2.64 | -2.57 | -2.70 | -2.73 |
| EPS Diluted | -4.54 | -4.23 | -4.12 | -4.32 | -4.36 |
| Normalized Diluted EPS | -2.84 | -2.64 | -2.57 | -2.70 | -2.73 |
| Average Basic Shares Outstanding | 86.61M | 85.30M | 82.69M | 78.47M | 74.36M |
| Average Diluted Shares Outstanding | 86.61M | 85.30M | 82.69M | 78.47M | 74.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |